Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
CHCC and Medicaid agency back prescription-drug monitoring bill; officials warn funding and eligibility limit rollout
Summary
CHCC and the Commonwealth Medicaid Agency told the Senate health committee that a prescription drug monitoring program (HB 24-36) would align the CNMI with national standards and unlock federal grant opportunities, but both agencies cautioned that sustainable local funding, procurement planning and state-plan amendments are required.
Jesse M. Tudela, chief operations officer at Commonwealth Healthcare Corporation, and George Cruz, director of the Commonwealth Medicaid Agency, urged senators to support House Bill 24-36 to establish a prescription drug monitoring program (PDMP) and to align statutory language with federal program and funding rules.
"Passage of house bill 24 dash 36 will align the CNMI with national standards and open the door to critical federal funding opportunities," Jesse Tudela said, emphasizing that…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
